The CIRS Regulatory and Reimbursement Atlas™ offers the following maps:
- Australia
- Austria
- Belgium
- Brazil
- Bulgaria
- China
- Croatia
- Cyprus
- Czech Republic
- Denmark
- England: NAS; Devices
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Japan
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Scotland
- Singapore
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Taiwan
- Thailand
- USA: CMS (medicare/medicaid)
- Wales
- Canada: CDR and pCODR
- Canada, Alberta: NAS; Onc; Devices
- Canada, British Columbia: NAS; Onc; Devices
- Canada, Manitoba: NAS; Onc
- Canada, New Brunswick: NAS; Onc
- Canada, Newfoundland and Labrador: NAS; Onc
- Canada, Northwest Territories: NAS; Onc
- Canada, Nova Scotia: NAS; Onc
- Canada, Nunavut: NAS; Onc
- Canada, Ontario: NAS; Onc; Devices
- Canada, Prince Edward Island: NAS; Onc
- Canada, Quebec: NAS and Onc
- Canada, Saskatchewan: NAS; Onc
- Canada, Yukon: NAS; Onc
CDR=Common Drug Review; NAS=new active substances; Onc=Oncology; pCODR=panCanadian Oncology Drug Review.
All maps listed are for NAS unless otherwise indicated.